These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 4989113

  • 1. Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin.
    Mitchell PS, Beller FK.
    Thromb Diath Haemorrh; 1970 Jun 30; 23(3):477-85. PubMed ID: 4989113
    [No Abstract] [Full Text] [Related]

  • 2. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
    Vanstone JC, Khoury NY.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(1):142-6. PubMed ID: 4996073
    [No Abstract] [Full Text] [Related]

  • 3. Detection of fibrinogen degradation products by use of antibody coated latex particles. The possibilities and limits of the method.
    Melliger EJ.
    Thromb Diath Haemorrh; 1970 May 31; 23(2):211-27. PubMed ID: 4193323
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood].
    Kotschy M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972 May 31; 98(4):426-36. PubMed ID: 4121336
    [No Abstract] [Full Text] [Related]

  • 5. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK, Mitchell PS, Gorstein F.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract] [Full Text] [Related]

  • 6. Fibrinogen break-down products and clotting parameters.
    Gormsen J, Laursen B.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):467-81. PubMed ID: 4231951
    [No Abstract] [Full Text] [Related]

  • 7. [Reversible stages of intravascular coagulation and their effect on kidney function and urokinase excretion].
    Theiss W, Graeff H, Bleyl U, Immich H, Kuhn W.
    Thromb Diath Haemorrh; 1970 May 31; 23(2):369-85. PubMed ID: 5310552
    [No Abstract] [Full Text] [Related]

  • 8. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S.
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct 31; 35(5):607-16. PubMed ID: 4677376
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
    Steichele DF, Herschlein HJ.
    Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):462-74. PubMed ID: 5590239
    [No Abstract] [Full Text] [Related]

  • 10. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
    Kudriashov BA, Molchanova LV, Kalishevskaia TM, Bazaz'ian GG, Pastorova VE, Sytina NP.
    Vopr Med Khim; 1969 Dec 31; 15(5):483-6. PubMed ID: 5368085
    [No Abstract] [Full Text] [Related]

  • 11. The structure of the fibrinogen degradation products.
    Marder VJ, Budzynski AZ.
    Prog Hemost Thromb; 1974 Dec 31; 2(0):141-74. PubMed ID: 4137300
    [No Abstract] [Full Text] [Related]

  • 12. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A, Straub PW.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):300-12. PubMed ID: 4271587
    [No Abstract] [Full Text] [Related]

  • 13. [Blood coagulation and fibrinolysis in premature and mature infants with respiratory distress syndrome and intracranial hemorrhage].
    Reddemann H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974 May 10; 101(3):426-50. PubMed ID: 4139062
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory effect of "late" type fibrinogen degradation products (FDP) upon the ethanol gelation of plasma.
    Sas G, Blaskó G, Jákó J, Bánhegyi D.
    Haematologia (Budap); 1973 May 10; 7(3):369-74. PubMed ID: 4275193
    [No Abstract] [Full Text] [Related]

  • 15. Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies.
    Marder VJ, Matchett MO, Sherry S.
    Am J Med; 1971 Jul 10; 51(1):71-82. PubMed ID: 4998883
    [No Abstract] [Full Text] [Related]

  • 16. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
    Nielsen VG.
    Acta Anaesthesiol Scand; 2005 Oct 10; 49(9):1263-71. PubMed ID: 16146462
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen-fibrin-related antigen pattern in human blood. Differences between plasma and serum from pateints with disseminated intravascular coagulation.
    Jacobsen CD, Hoak JC, Wu KK, Fry GL.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):266-76. PubMed ID: 4217475
    [No Abstract] [Full Text] [Related]

  • 18. [Experimental immune hemolysis and blood coagulation].
    Janzarik H, Köppler E, Lasch HG.
    Thromb Diath Haemorrh; 1971 Aug 31; 26(1):22-8. PubMed ID: 5112375
    [No Abstract] [Full Text] [Related]

  • 19. [Congenital dysfibrinogenemia. Report on a new family (fibrinogen "Wiesbaden")].
    Winckelmann G.
    Thromb Diath Haemorrh Suppl; 1973 Aug 31; 55():345-56. PubMed ID: 4216115
    [No Abstract] [Full Text] [Related]

  • 20. [Characteristics of the coagulative and immunological properties of fibrinogen degradation products].
    Fedorova ZD, Paradeeva IK, Zhukova IV, Elizarova AI, Pshenichnaia LN.
    Probl Gematol Pereliv Krovi; 1980 Jan 31; 25(1):44-6. PubMed ID: 6768062
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.